Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse

INSIDE INFORMATION REGULATED INFORMATION Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse Mont-Saint-Guibert (Belgium), September 14, 2021, 8:00 am CET / 2:00 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and […]

Francesco Tanzi named Chief Financial Officer of new Iveco Group

CNH INDUSTRIAL N.V. London, September 14, 2021 CNH Industrial (NYSE: CNHI / MI: CNHI) announces an important appointment to the future Senior Leadership Team of Iveco Group, the Company previously referred to as the “On-Highway” business of CNH Industrial, which will begin independent operations in early 2022. Effective January 1, 2022, Francesco Tanzi will join […]

KnowledgeIQ, a Solution by Knosys, Announces Its Integration With Salesforce for Improved Customer and Agent Experience

PORT MELBOURNE, Australia, Sept. 14, 2021 (GLOBE NEWSWIRE) — Knosys today announced that its knowledge management solution, KnowledgeIQ (www.knoiq.co) has launched a new integration with Salesforce. With KnowledgeIQ and Salesforce, your customer-facing teams can effortlessly access the right information and answers sourced from their entire business to make sales, drive exceptional customer experiences and improve […]

Positive Interim Results of CHOICE-01 Study Evaluating Junshi Biosciences and Coherus’ Toripalimab for First Line Treatment of Non-Small Cell Lung Cancer Presented at World Conference on Lung Cancer

SHANGHAI, China and REDWOOD CITY, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus Biosciences, Inc. (Nasdaq: CHRS) announced the presentation today of positive interim results from the pivotal study “CHOICE-01” (NCT03856411), a randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating toripalimab plus chemotherapy […]

AGC Biologics Expands pDNA and mRNA Manufacturing Capacity at Heidelberg Facility

Heidelberg, Germany, Sept. 13, 2021 (GLOBE NEWSWIRE) — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced expansion plans for the company’s Heidelberg facility to increase manufacturing capacities for plasmid-DNA (pDNA) and messenger RNA (mRNA) projects. With this expansion, AGC Biologics is boosting its current 100L and 1,000L manufacturing capacities for a […]

Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference

Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference Mont-Saint-Guibert (Belgium), September 13, 2021, 10:30 pm CET / 4:30 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that […]